NAMS Position Statements

NAMS: The 2017 Hormone Therapy Position Statement A panel of clinicians and researchers expert in the field of women's health and menopause has revised the NAMS 2012 Position Statement with updated recommendations and areas for future research.
Journal Article, February 08, 2018
Nonhormonal Management of Vasomotor Symptoms of Menopause What are the most common and effective ways of managing the vasomotor symptoms of menopause without the use of hormones?
Journal Article, January 25, 2016
Use of Systemic Hormone Therapy After Age 65 Is hormone therapy safe and effective in women over age 65 with vasomotor symptoms of menopause, and what should clinicians consider when prescribing for their older patients?
Journal Article, July 06, 2015
NAMS: The 2012 Hormone Therapy Position Statement What does the latest position statement from the North American Menopause Society say about the use of various hormone therapies for menopausal and postmenopausal women?
March 01, 2012
NAMS Position Statement: Management of Osteoporosis Read the latest recommendations from the North American Menopause Society on the management of osteoporosis in postmenopausal women.
June 30, 2011
NAMS on Local Estrogen for Vaginal Atrophy An evidence-based position statement published by The North American Menopause Society (NAMS) on the role of local vaginal estrogen therapy (ET) for the treatment of vaginal atrophy in postmenopausal
May 13, 2008

No Results